Recent Headlines
Within Pharmaceuticals
NanoHybrids Launches Gold Nanoparticles Custom Designed to Improve Lateral Flow Quality and Reproducibility
Careful selection of indicator particles is absolutely critical to the performance of any lateral flow assay. NanoHybrids’ new line of monodisperse gold nanoparticles can enable the development of lateral flow assays that meet the highest specifications of the industry, particularly with respect to sensitivity and reproducibility. - August 16, 2015 - NanoHybrids
IQ4I Research & Consultancy Published a New Report on “Health Information Exchange Global Market": Estimated to be Worth $1.3 Billion by 2021
The global Health information exchange market is expected to reach $1.3 billion by 2021. This report analyzes the health information exchange market in terms of market revenue ($ million) for all segments. - August 15, 2015 - IQ4I Research & Consultancy Pvt. Ltd.
Eurogentec (EGT), Belgium, Appoints MoBiTec GmbH as Distributor for Germany
Eurogentec (EGT) is a leading provider of innovative products and services to the life science, diagnostic, and pharmaceutical community. MoBiTec is selling the products of AnaSpec, which now is part of EGT, for more than 10 years already. The agreement allows MoBiTec to also offer EGT's state-of-the-art qPCR kits, oligonucleotides, and further products related to genomics to its customers. - August 14, 2015 - MoBiTec GmbH
Source-Omega Lowers Bulk Algae Oil DHA Price 33 Percent
Achieving higher quality and lower costs, Source-Omega (http://www.source-omega.com) today lowered the US bulk oil price on premium 50 percent DHA algae oil by a third to stimulate their open source supply model with capacity access to 250,000 Kg per year. The company launched their bulk oil... - August 13, 2015 - Source-Omega
KinderPharm Raises $1 Million to Further Advance Pediatric Drug Development
KinderPharm, a full-service contract research organization (CRO) dedicated exclusively to pediatric drug development, has raised $1 million from a Series A comprised of individuals, companies and angel investors. The $1 million investment will be used to further advance the clinical development of new medicines for children. - August 13, 2015 - KinderPharm LLC
Mostly Medicaid Addresses Society of Actuaries on OIG Scrutiny of State Medicaid Financing Mechanisms (IGTS, Provider Taxes, UPL and DSH)
Mostly Medicaid experts assisted the Society of Actuaries in reviewing recent moves by federal HHS OIG to resume scrutiny of state financing methods such as intergovernmental transfers, upper payment limit calculations and provider taxes. Clay Farris of Mostly Medicaid predicts a new wave of... - August 13, 2015 - Mostly Medicaid
Mostly Medicaid Addresses Society of Actuaries on Key Aspects of New Medicaid Regulations
Mostly Medicaid experts assisted the Society of Actuaries in reviewing the new CMS Medicaid Managed Care regulations. The regulations are expected to have significant impact to the Medicaid industry, and Mostly Medicaid provides critical insights into how stakeholders can respond to the changing managed care landscape. - August 13, 2015 - Mostly Medicaid
ABR Launches Bovine Polyomavirus Testing Service
ABR (now a VMRD division) announced today the availability of a new testing service that can detect the presence of bovine polyomavirus (BPyV) in animal origin products, master virus seeds, and other sample types. This infectivity assay, without using non-infectivity assays such as PCR, has the... - August 12, 2015 - VMRD, Inc.
Gensco Labs Announces LiDORx® Copay Program Mobile Platform for Pain Management
Text “LIDO to 37500” on your mobile device to receive the benefits of the Program Gensco Laboratories™ (www.genscolabs.com), A Specialty Pharmaceutical Company, announces a new mobile platform that uses innovative smart phone technology to provide copay assistance and facilitate... - August 11, 2015 - Gensco Labs
ADC Contract Manufacturing Market: Opportunities Ahead
Antibody Drug Conjugates (ADCs) are a new class of therapeutic drugs consisting of a cytotoxic drug linked to a monoclonal antibody. These novel conjugates are believed to be very effective and efficient in treatment of a disease. However, manufacturing such highly potent toxic molecules is accompanied with several known and unknown challenges. - August 10, 2015 - Roots Analysis
Matrix Medical Releases TRACTUS Video, World's First Sterile Scanner Showcased
Matrix Medical, a Wisconsin company, has unveiled the first ever sterile scanner, TRACTUS. A video has been released showcasing how the scanner can easily scan 2D data matrix codes in the sterile field. - August 09, 2015 - Matrix Medical Tracking Systems
Dr Nader N Youssef Appointed Chief Medical Officer of electroCore
Dr Nader N Youssef has been appointed Chief Medical Officer of electroCore, the US based electroceutical healthcare company. Nader brings more than 15 years of clinical, academic, and industry research experience to electroCore. He was previously Executive Director GI Global Clinical Development... - August 09, 2015 - electroCore
TRACTUS Launched as Comprehensive Solution to FDA UDI Final Rule
Medical devices are an integral part of the health care system. Advances in devices and implants has led to a longer and improved quality of life for countless patients. However, not all interactions with medical devices have proven trouble-free. Recalls, Adverse events, and post-market... - August 07, 2015 - Matrix Medical Tracking Systems
Pinnacle 21 CEO Max Kanevsky Named to PharmaVOICE 100
Pinnacle 21 announced today that its president & CEO, Max Kanevsky, has been named to the prestigious PharmaVOICE 100 list of the most innovative and influential people in the life-sciences industry. - August 07, 2015 - Pinnacle 21
Fertility Preservation Network Welcomes Huntington, West Virginia Area Facility
Program greatly extends access to fertility preservation services. - August 07, 2015 - ReproTech, LLC
The Musculoskeletal Transplant Foundation Agrees to Invest in AmnioChor
AmnioChor is a biotech startup engaged in perinatal stem cell technologies, founded with a long term vision and operating on a near term mandate. The vision is the ability to satisfy the therapeutic needs of Mesenchymal and Epithelial stem cells as the critical high volume foundation of new cures. The immediate mandate is to create the bank to serve that need through the cryopreservation of the living amniotic membrane of the placental sac. - August 06, 2015 - AmnioChor
Noninvasix Announces Formation of Scientific Advisory Board
Appoints Critical Care Obstetrics Expert, Gary D. Hankins, M.D. - August 06, 2015 - Noninvasix
Vitamin Weed: Get Healthy, Not High: Big Brother Star Launches Crowdfunding Campaign for Cannabis Book
Dr. Michele Noonan Ross plans to educate both patients and doctors with her new book Vitamin Weed: Get Healthy, Not High, a revolutionary 4-step plan to reversing endocannabinoid deficiency and restoring balance to your body. Launching July 22nd on the Publishizer crowdfunding platform, 10% of book sales will be donated to the Endocannabinoid Deficiency Foundation to directly fund cannabinoid research. - August 06, 2015 - GreenStone Labs
Motorcyclists in Three States Help Children with Brain Tumors
Ride for Kids motorcyclists gathered in three states over the weekend and raised $103,927 for the Pediatric Brain Tumor Foundation. The events in Michigan, New York and Pennsylvania honored 25 local brain tumor survivors on Aug. 2: Andrea, Andrew, Angel, Annabelle, Bo, Catie, Gianna, James, Jon,... - August 05, 2015 - Pediatric Brain Tumor Foundation
Community Scripts LLC Awarded National Minority Supplier Development Council® Minority Business Enterprise (MBE) Certification
Community Scripts, LLC is now a National Minority Supplier Development Council, Inc. (NMSDC) certified Minority Business Enterprise (MBE). - August 05, 2015 - Community Scripts
Israel Patent Allowance for GH, IGF-1 and Obesity Vaccines to Braasch Biotech
Israel Patent Office allows patent for treatment of hormone deficiencies and obesity in humans and pets. - August 01, 2015 - Braasch Biotech LLC
New Product Launched to Safeguard Patients from Counterfeit Medical Implants and Improved Recall Accuracy
New technology tracks medical implants; guards against counterfeits and offers ability to match recalls with patients. Matrix Medical announces the comprehensive TRACTUS solution to fill a much needed industry need. Product is fully in adherence to the GUDID and UDI requirements laid out by FDA. - July 29, 2015 - Matrix Medical Tracking Systems
Fannin Innovation Studio Expands Team as Life Science Portfolio Grows
Dr. Michael Heffernan to lead R&D of novel biomedical technologies. - July 29, 2015 - Fannin Partners, LLC
Riders in Midwest, South Raise Funds for the PBTF
From the southern hills to the Midwestern plains, Ride for Kids motorcyclists combined to raise more than $90,000 for the Pediatric Brain Tumor Foundation on July 26. More than 300 participants attended the East Tennessee and Kansas City Ride for Kids events to honor their local brain tumor... - July 29, 2015 - Pediatric Brain Tumor Foundation
RIPPTILE Launches New Supplement Products for Successful Fitness Goals in Las Vegas NV
RIPPTILE is a fitness company which is launching a new line of supplemental products to help users achieve their fitness goals. With top quality supplements, customers will take advantage of effective fitness products including Ripptile Whey Protein, Ripptile Vennom, and Muscle Maker III. The new... - July 28, 2015 - RIPPTILE
New Technology from MR Solutions Could Mean That Our Children Can Still Have Helium Party Balloons in the Future
Helium filled party balloons could be relegated to the past if the supply of helium dwindles, but MR Solutions, the world technology leader in preclinical MRI systems could be riding to the rescue with scanners that do not require liquid helium. - July 25, 2015 - MR Solutions
Fannin Innovation Studio and University of Houston Announce the Formation of GuidaBot, LLC
Technology enables interventions using real-time MRI guidance. - July 25, 2015 - Fannin Partners, LLC
ViridisChem, Inc. Announces the Key Member of Advisory Board Dr. David Constable
ViridisChem, Inc. San Jose, CA is excited to welcome Dr. David Constable, a well-respected scientist and industry expert in the field of green chemistry, as a Technical Advisor to guide through the development of company’s portfolio of software products. - July 24, 2015 - ViridisChem, Inc.
Tredence Announces Sponsorship of Tableau Customer Conference 2015
Tredence is proud to be a Tableau partner and Kilobyte Sponsor of Tableau Customer Conference 2015. - July 24, 2015 - Tredence Inc.
Speaking of NEC Podcast Featuring Dr. Naveed Hussain Launches July 28
Produced by The Morgan Leary Vaughan Fund, and funded by The Petit Family Foundation, Speaking of NEC is a series of one-on-one conversations with relevant Necrotizing Enterocolitis (NEC) experts—neonatologists, clinicians and researchers—that highlights current prevention, diagnosis, and treatment strategies for NEC, and the search for a cure. - July 24, 2015 - The Morgan Leary Vaughan Fund, Inc.
Bioo Scientific Increases Multiplexing Capabilities for Illumina Sequencing with >2000 Single-Index Barcodes
Bioo Scientific has released NEXTflex-HT™ Barcodes, single-index barcodes for Illumina sequencing, significantly increasing throughput capacity for next generation sequencing. The NEXTflex-HT Barcodes permit dual error correction to preventing ambiguity in sample differentiation due to PCR errors or sequencing instrument miscalling. Each pair of consecutive barcodes is fully color balanced and suitable for low level multiplexing. - July 24, 2015 - Bioo Scientific
Acne Vulgaris - API Insights - A DelveInsight Report
DelveInsight, the leading market research and consulting company has added new report, Acne Vulgaris-API Insights, 2015 to its portfolio. With this launch Delveinsight now has 400+ Reports on Indication API Insight. DelveInsight is the only company that promulgates API Insight Reports. In addition... - July 24, 2015 - DelveInsight
MiTeGen Announces Mutual Distribution Agreements with Rigaku Reagents
MiTeGen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced that it has signed mutual distribution agreements with Rigaku Reagents. - July 23, 2015 - MiTeGen, LLC
Fertility Preservation Network Welcomes Raleigh, North Carolina Area Facility
Program greatly extends access to fertility preservation services. - July 23, 2015 - ReproTech, LLC
NanoHybrids Enters into Distribution Agreement with Eikonix
NanoHybrids Inc, a biotechnology company based in Austin, Texas, and Eikonix, UK, a distributor of imaging systems and contrast agents announced today that they have entered into an agreement that adds NanoHybrids’ premium gold nanoparticles to Eikonix's extensive offering of scientific... - July 23, 2015 - NanoHybrids
Global Biosimilars Market, 2015-2025
Characterised by increased utility in chronic diseases and capital intensive manufacturing, the global biopharmaceutical market is expanding robustly. As the demand for biologics is increasing continuously, manufacturers are on the lookout for novel strategies that will help them attain maximum returns on investment. - July 22, 2015 - Roots Analysis
Data-Driven Care Transition Management Delivers Action Plans for High-Risk Patients
A new Healthcare Intelligence Network report documents development of data tools by a San Francisco Task Force that streamlines care transitions for safety net patients. - July 22, 2015 - Healthcare Intelligence Network
Ride for Kids Crosses Borders to Raise Funds for PBTF
Ride for Kids motorcyclists rode in three states to raise $392,428 for the Pediatric Brain Tumor Foundation over the weekend. Riders in Minnesota, New York and Wisconsin honored 27 brain tumor survivors on July 19: Alyona, Amanda, April, Beckett, Carra, Catrina, Connor, Dominic, Emily, Hunter,... - July 22, 2015 - Pediatric Brain Tumor Foundation
Drip & Prep – RNA Isolation Has Never Been so Easy; FortiusBio LLC do Cell Lysis Cards to the Utmost
MoBiTec GmbH's new partner FortiusBio LLC is a US startup biotech firm that does only one thing good: to soak filter paper with proprietary lysis solutions and make cards which lyse cells and preserve nucleic acid (even RNA) integrity at room temperature. - July 22, 2015 - MoBiTec GmbH
Accountable Care Evolution from 2011-2015: 8 Year-Over-Year Trends
Today's ACOs are larger, busier and better staffed than they were four years ago, according to a year-over-year analysis contained in a new report, 2015 Healthcare Benchmarks: Accountable Care Organizations. - July 21, 2015 - Healthcare Intelligence Network
Integrating Behavioral Health and Primary Care in 2015: One-Third Achieve Close Collaboration On-Site
Sixty-two percent of healthcare organizations have achieved some level of behavioral health and primary care integration, according to new market metrics from the Healthcare Intelligence Network. - July 20, 2015 - Healthcare Intelligence Network
US Pharmaceutical Corporation Utilizes Probiotic Ferment Skin Care Technology to Drastically Improve Skin Peel Applications
US Pharmaceutical Corporation, one of the leading probiotic research and commercialization companies in the world, introduces a new collection of probiotic ferment-based micro skin peel products. The probiotic ferment technology is applied in a 24 hour micro peel regimen, which archives similar results to common peel systems, but without the side effects of redness/irritation and flaking of the skin. - July 20, 2015 - US Pharmaceutical Corporation
The Balancing Act® Talks Blood Clotting Disorder Dangerous for New Moms; Boosting Careers with Online Math & Science Courses
Troy University and “Behind the Mystery – Rare and Genetic Diseases Series” features Hereditary AT Deficiency, potentially deadly for pregnant and new moms, on July 20 Show on Lifetime. - July 19, 2015 - BrandStar
IQ4I Research & Consultancy Published a New Report on "Non-Alcoholic Steatohepatitis (NASH) Pipeline Analysis"
The report covers all the drugs being developed in various phases (Discovery, Preclinical & Clinical development). The pipeline focuses on novel medicines covering small molecules, monoclonal antibodies, Recombinant proteins and RNA-based therapeutics, but excludes Off-label, symptom relief drugs, generic combinations. - July 18, 2015 - IQ4I Research & Consultancy Pvt. Ltd.
Medtown Ventures, LLC Announces Exclusive License Agreement with Georgia Tech Research Corporation
Medtown Ventures forms a new company, CellectCell Inc., to focus on commercialization of adhesive-signature based cell selection technology invented and patented by Georgia Tech. - July 17, 2015 - Medtown Ventures
Noninvasix Joins Leading California-Based Pediatric Device Consortium
Houston medical device startup Noninvasix, Inc., developers of a noninvasive brain oxygenation monitor for the NICU, is collaborating with the Consortium of Technology and Innovation in Pediatrics (CTIP) to accelerate the development of its advanced prototype, navigate the FDA regulatory process... - July 17, 2015 - Noninvasix
The Journal of Headache and Pain Reports That electroCore’s Non-Invasive Vagus Nerve Stimulation (nVNS) Treatment is Effective in Migraines
-- 65% of the study participants reported pain relief(1) by 2 hours after treatment, with 56% already reporting pain relief by one hour, and 35% were pain free by one hour -- Authors stated that nVNS was safe, well tolerated and effective in many patients and may reduce medication overuse and... - July 17, 2015 - electroCore
DelveInsight’s Oncology Based Reports, 2015
DelveInsight, the leading market research and consulting company has added Oncology based Reports to its portfolio. With this launch DelveInsight now has 100+ Oncology based Reports. In addition to this, their research expertise provides their clients with up to date information of market till the date on which order is placed. - July 17, 2015 - DelveInsight
Non-Tyrosine Kinase Inhibitors Market to Witness 9% Annualized Growth, Predicts Roots Analysis
Roots Analysis has announced the addition of “Non-Tyrosine Kinase Inhibitors in Oncology, 2015-2025” report to their offering. The report provides a comprehensive analysis of the current market landscape and the future outlook of kinase inhibitors not specifically targeting tyrosine... - July 16, 2015 - Roots Analysis
A Fully Functional Diagnostic Laboratory in a Box - MoBiTec GmbH, Germany, Offers Coyote Bioscience's MD-Box-Lab
Whether a veterinarian in the field or a tropical disease specialist in the savanna - one of the things they certainly do miss most is a fully operational laboratory for reliable molecular biologically supported diagnostics. - July 15, 2015 - MoBiTec GmbH